A. Vega Castro (Guadalajara, Spain)

Chairs: A. Vega Castro (Guadalajara, Spain) and M. Ollert (Esch-sur-Alzette, Luxembourg)

Lectures:

1. Update in mast cell diseases – new drugs, I. Alvarez Twose (Toledo, Spain)

2. Management of mastocytosis and HVA, P. Bonadonna (Verona, Italy)

3. Hereditary alpha-tryptasemia (HAT) and Hymenoptera, D. González-Olano (Madrid, Spain)

Q&A

Chairs: E. Boni (Bologna, Italy) and H. Oude Elberink (Haren, Netherlands)

Lecture:

A gold standard tool in diagnosis and treatment?, G. Sturm (Graz, Austria)

Q&A

Chairs: M. Martini (Ancona, Italy) and T. Alfaya Arias (Madrid, Spain)

1. Hymenoptera Venom Allergy in patients with Systemic Mastocytosis: the importance of specific IgE associated with skin tests, F. Noreli (Verona, Italy)

2. Prospective Comparison of the Efficacy of 3 month extended Venom Immunotherapy (VIT) Administration in Patients with Mastocytosis Versus Conventional Treatment, G. Sfriso (Verona, Italy)

3. Selection of the best commercial immunotherapy through CAP Inhibition in patients with anaphylaxis due to Vespa velutina, S. Carreras-Kàtcheff (Barcelona, Spain)

Chairs: K. Spriggs (Parkvile, Australia) and C. Breynaert (Leuven, Belgium)

Lectures:

1. Insect identification and behavior, F.J. Ortiz Sánchez (La Cañada (Almería), Spain)

2. Diagnostic algorithm, M. Martini (Ancona, Italy)

3. Key points to prescribe venom immunotherapy, E. Boni (Bologna, Italy)

Q&A

Workshop Session:

Venom products: adapting diagnosis and treatment, B.M. Bilò (Ancona, Italy) and E. Boni (Bologna, Italy)

Workshop Session:
Sting challenge test, T. Alfaya Arias (Madrid, Spain) and B. Ruíz-León (Córdoba, Spain)

Workshop Session:

1. Handling VIT adverse reactions, L. Marques (Lleida, Spain)

2. Risk factors in HVA, C. Breynaert (Leuven, Belgium)

Chairs: D. González-Olano (Madrid, Spain) and B.M. Bilò (Ancona, Italy)

Lecture:

HVA and patient profile: diagnostic accuracy, A. Vega Castro (Guadalajara, Spain)

Q&A

Chairs: T. Jakob (Giessen, Germany) and F.J. Ortiz Sánchez La Cañada (Almería), Spain

Lectures:
1. Rare and emerging insect allergy, K. Spriggs (Parkvile, Australia)

2. Environmental factors (climate change, pollution…) and One Health Approach, A. Vega Castro (Guadalajara, Spain)

3. Bumblebee venom allergy as a model of occupational disease, C. Breynaert (Leuven, Belgium)

Q&A

Chairs: K. Spriggs (Parkvile, Australia), L. Marques (Lleida, Spain)
Study of the immune system changes during bee venom immunotherapy, N. Blanco Toledano (Córdoba, Spain)

Evaluation of the negative predictive value of the Sting Challenge Test, T. Alfaya Arias (Alcorcón, Spain)

Vespa crabro venom: accuracy of common diagnostic tests, A. Carbone (Bologna, Italy)

Chairs : P. Korosec (Golnik, Slovenia) and G. Sturm (Graz, Austria)

Lectures:

1. Mastocytosis: How to avoid the long road to diagnosis?, T. Rama (Porto, Portugal)

2. Can we maintain the old epidemiological statements?, M. Martini (Ancona, Italy)

3. Does sensitization equal HVA in mastocytosis patients?, H. Oude Elberink (Haren, Netherlands)

4. A sight on VIT protocols, T. Alfaya Arias (Madrid, Spain)

Q&A